| Original Research Online Published: 05 May 2018 | ||||||||||||
Int J Med Rev Case Rep. 2018; 2(4): 136-142 Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy Dinie Ramdhani Kusuma, Safruddin Amin, Khairuddin Djawad, Srivitayani Muchtar, Sitti Nur Rahmah, Idham Jaya Ganda, Agussalim Bukhari.
| ||||||||||||
This Article Cited By the following articles
| Efficacy of clofazimine against acute and chronic Toxoplasma gondii infection in mice Microbial Pathogenesis 2023; 181(): 106206. | 1 |
| How to Cite this Article |
| Pubmed Style Kusuma DR, Amin S, Djawad K, Muchtar S, Rahmah SN, Ganda IJ, Bukhari A. Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. Int J Med Rev Case Rep. 2018; 2(4): 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy Web Style Kusuma DR, Amin S, Djawad K, Muchtar S, Rahmah SN, Ganda IJ, Bukhari A. Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. https://www.mdpub.net//?mno=297595 [Access: June 23, 2026]. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy AMA (American Medical Association) Style Kusuma DR, Amin S, Djawad K, Muchtar S, Rahmah SN, Ganda IJ, Bukhari A. Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. Int J Med Rev Case Rep. 2018; 2(4): 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy Vancouver/ICMJE Style Kusuma DR, Amin S, Djawad K, Muchtar S, Rahmah SN, Ganda IJ, Bukhari A. Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. Int J Med Rev Case Rep. (2018), [cited June 23, 2026]; 2(4): 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy Harvard Style Kusuma, D. R., Amin, . S., Djawad, . K., Muchtar, . S., Rahmah, . S. N., Ganda, . I. J. & Bukhari, . A. (2018) Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. Int J Med Rev Case Rep, 2 (4), 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy Turabian Style Kusuma, Dinie Ramdhani, Safruddin Amin, Khairuddin Djawad, Srivitayani Muchtar, Sitti Nur Rahmah, Idham Jaya Ganda, and Agussalim Bukhari. 2018. Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. International Journal of Medical Reviews and Case Reports, 2 (4), 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy Chicago Style Kusuma, Dinie Ramdhani, Safruddin Amin, Khairuddin Djawad, Srivitayani Muchtar, Sitti Nur Rahmah, Idham Jaya Ganda, and Agussalim Bukhari. "Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy." International Journal of Medical Reviews and Case Reports 2 (2018), 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy MLA (The Modern Language Association) Style Kusuma, Dinie Ramdhani, Safruddin Amin, Khairuddin Djawad, Srivitayani Muchtar, Sitti Nur Rahmah, Idham Jaya Ganda, and Agussalim Bukhari. "Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy." International Journal of Medical Reviews and Case Reports 2.4 (2018), 136-142. Print. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy APA (American Psychological Association) Style Kusuma, D. R., Amin, . S., Djawad, . K., Muchtar, . S., Rahmah, . S. N., Ganda, . I. J. & Bukhari, . A. (2018) Comparison of Total Antioxidant Capacity (TAC) in the Multibacillary (MB) Type of Leprosy Patients Before and After 3 Months of MDT-MB WHO Therapy. International Journal of Medical Reviews and Case Reports, 2 (4), 136-142. doi:10.5455/IJMRCR.total-antioxidant-capacity-multibacillary-type-leprocy |
